Ultraformer MPT is a medical-grade high-intensity focused ultrasound platform used in considered facial work for skin laxity and contour support. This article is the higher-level companion to the deeper mechanism piece on macro-pulsed technology already in the Journal. The intent here is to answer the practical question patients tend to ask first: what is it, and what is it doing under the skin.
What HIFU is
HIFU stands for high-intensity focused ultrasound. Ultrasound is sound energy delivered at frequencies above the range of human hearing. When that energy is focused to a precise point beneath the skin, it generates a small, controlled zone of thermal stimulation in a specific tissue plane. Skin and tissue above and below that focal point are largely spared. The body responds to the controlled stimulation through its own wound-healing cascade, which over weeks and months is associated with increased collagen and elastin production in the treated layer.
What MPT means
MPT stands for macro-pulsed technology, the pulse architecture that distinguishes the Ultraformer platform. Rather than delivering energy in long continuous bursts, the device emits short sub-millisecond macro-pulses. The clinical rationale, discussed in more detail in the companion mechanism article, is that the macro-pulsed delivery is associated with improved tolerability and more consistent thermal coagulation points across a treatment area.
Where the energy goes
The platform uses interchangeable transducers tuned to specific focal depths, commonly reported around 1.5 mm, 3.0 mm and 4.5 mm. Each depth corresponds to a different tissue plane:
- · Around 1.5 mm: the superficial and mid-dermis, associated with skin quality and fine surface support.
- · Around 3.0 mm: the deeper dermis, associated with dermal thickness and firmness.
- · Around 4.5 mm: the superficial musculoaponeurotic system, the SMAS, associated with structural lift in suitable candidates.
The choice of depth, or combination of depths, is made by the treating clinician based on anatomy and the clinical objective discussed at consultation.
What it is designed to support
Patients consider Ultraformer MPT for hedged outcomes that may include:
- · Mild to moderate skin laxity through the lower face.
- · Jawline definition and perceived contour.
- · Skin firmness through the neck and under-chin area.
- · Skin quality on the décolletage.
It is not a substitute for surgery. Patients with significant structural laxity are typically better served by a surgical consultation. The platform sits in the non-surgical, regenerative end of the planning conversation.
How it fits in a regenerative plan
Ultraformer MPT is typically used as the structural layer of a broader plan. It may be paired with bio-remodelling for dermal hydration, medical skin needling for surface texture, polynucleotide skin boosters for skin quality, and a cosmeceutical regimen for daily support. Sessions are sequenced and reviewed across months, with maintenance considered through a shorter booster session where appropriate.
Consultation, suitability and risks
Suitability is established in a one-on-one medical consultation under the clinical governance of FRACS Plastic and Reconstructive Surgeons. Common transient responses can include short-lived tenderness, mild swelling, and small areas of redness. Less common risks are discussed in detail at consultation. All cosmetic procedures carry risks and results vary.
This article is general information only and is not medical advice.